← FDA Drug Approvals (Drugs@FDA)

REZZAYO

NDA · New Drug Application · Sponsor: MUNDIPHARMA · Approved 2023-03-22

Drug application

FDA Application #

NDA217417

Application type

New Drug Application

Brand name

REZZAYO

Generic name

REZAFUNGIN

Active ingredients

REZAFUNGIN ACETATE

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

MUNDIPHARMA

Manufacturer

Melinta Therapeutics, LLC

First approval

2023-03-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown